Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Proc Natl Acad Sci U S A ; 114(10): 2681-2686, 2017 03 07.
Article in English | MEDLINE | ID: mdl-28213497

ABSTRACT

The innate immune system senses RNA viruses by pattern recognition receptors (PRRs) and protects the host from virus infection. PRRs mediate the production of immune modulatory factors and direct the elimination of RNA viruses. Here, we show a unique PRR that mediates antiviral response. Tetrachlorodibenzo-p-dioxin (TCDD)-inducible poly(ADP ribose) polymerase (TIPARP), a Cysteine3 Histidine (CCCH)-type zinc finger-containing protein, binds to Sindbis virus (SINV) RNA via its zinc finger domain and recruits an exosome to induce viral RNA degradation. TIPARP typically localizes in the nucleus, but it accumulates in the cytoplasm after SINV infection, allowing targeting of cytoplasmic SINV RNA. Redistribution of TIPARP is induced by reactive oxygen species (ROS)-dependent oxidization of the nuclear pore that affects cytoplasmic-nuclear transport. BCL2-associated X protein (BAX) and BCL2 antagonist/killer 1 (BAK1), B-cell leukemia/lymphoma 2 (BCL2) family members, mediate mitochondrial damage to generate ROS after SINV infection. Thus, TIPARP is a viral RNA-sensing PRR that mediates antiviral responses triggered by BAX- and BAK1-dependent mitochondrial damage.


Subject(s)
Immunity, Innate/genetics , Poly(ADP-ribose) Polymerases/genetics , RNA Viruses/genetics , Receptors, Pattern Recognition/genetics , Active Transport, Cell Nucleus/genetics , Active Transport, Cell Nucleus/immunology , Cytoplasm/genetics , Cytoplasm/immunology , Host-Pathogen Interactions/genetics , Host-Pathogen Interactions/immunology , Humans , Mitochondria/genetics , Mitochondria/pathology , Mitochondria/virology , Nucleoside Transport Proteins , Poly(ADP-ribose) Polymerases/immunology , RNA Viruses/immunology , Reactive Oxygen Species/metabolism , Receptors, Pattern Recognition/immunology , Sindbis Virus/genetics , Sindbis Virus/immunology , Sindbis Virus/pathogenicity , bcl-2 Homologous Antagonist-Killer Protein/genetics , bcl-2 Homologous Antagonist-Killer Protein/immunology , bcl-2-Associated X Protein/genetics , bcl-2-Associated X Protein/immunology
2.
Cell Death Dis ; 7: e2134, 2016 Mar 10.
Article in English | MEDLINE | ID: mdl-26962684

ABSTRACT

LTX-315 is a cationic amphilytic peptide that preferentially permeabilizes mitochondrial membranes, thereby causing partially BAX/BAK1-regulated, caspase-independent necrosis. Based on the observation that intratumorally injected LTX-315 stimulates a strong T lymphocyte-mediated anticancer immune response, we investigated whether LTX-315 may elicit the hallmarks of immunogenic cell death (ICD), namely (i) exposure of calreticulin on the plasma membrane surface, (ii) release of ATP into the extracellular space, (iii) exodus of HMGB1 from the nucleus, and (iv) induction of a type-1 interferon response. Using a panel of biosensor cell lines and robotized fluorescence microscopy coupled to automatic image analysis, we observed that LTX-315 induces all known ICD characteristics. This conclusion was validated by several independent methods including immunofluorescence stainings (for calreticulin), bioluminescence assays (for ATP), immunoassays (for HMGB1), and RT-PCRs (for type-1 interferon induction). When injected into established cancers, LTX-315 caused a transiently hemorrhagic focal necrosis that was accompanied by massive release of HMGB1 (from close-to-all cancer cells), as well as caspase-3 activation in a fraction of the cells. LTX-315 was at least as efficient as the positive control, the anthracycline mitoxantrone (MTX), in inducing local inflammation with infiltration by myeloid cells and T lymphocytes. Collectively, these results support the idea that LTX-315 can induce ICD, hence explaining its capacity to mediate immune-dependent therapeutic effects.


Subject(s)
Antineoplastic Agents/pharmacology , Immunity, Cellular/drug effects , Neoplasms/immunology , Oligopeptides/pharmacokinetics , T-Lymphocytes/immunology , bcl-2 Homologous Antagonist-Killer Protein/immunology , bcl-2-Associated X Protein/immunology , Cell Death , Cell Line, Tumor , Humans , Neoplasms/pathology , Neoplasms/therapy , T-Lymphocytes/pathology
3.
Cold Spring Harb Protoc ; 2015(5): 472-6, 2015 May 01.
Article in English | MEDLINE | ID: mdl-25934937

ABSTRACT

Activation of both Bax and Bak during apoptosis involves significant conformation change. Investigation of this phenomenon by immunoprecipitation (IP) requires a detergent such as CHAPS that does not induce significant conformation change. IP with conformation-specific Bax or Bak antibodies is observed in CHAPS only following an apoptotic stimulus, whereas the same antibodies will immunoprecipitate from both nonapoptotic and apoptotic cells in the presence of Triton X-100. Thus, the latter detergent can serve as a positive control for IP, as described here.


Subject(s)
Immunoprecipitation/methods , bcl-2 Homologous Antagonist-Killer Protein/chemistry , bcl-2 Homologous Antagonist-Killer Protein/metabolism , bcl-2-Associated X Protein/chemistry , bcl-2-Associated X Protein/metabolism , Animals , Antibodies/immunology , Antibodies/metabolism , Detergents , Humans , Octoxynol , Protein Conformation , bcl-2 Homologous Antagonist-Killer Protein/immunology , bcl-2-Associated X Protein/immunology
4.
Cold Spring Harb Protoc ; 2015(5): 477-80, 2015 May 01.
Article in English | MEDLINE | ID: mdl-25934938

ABSTRACT

Like the commonly used immunoprecipitation (IP) approach, this procedure for the detection of activated Bak or Bax by intracellular flow cytometry is based on the principle that Bak and Bax, during activation, expose occluded amino-terminal epitopes that can be recognized by conformation-specific antibodies. Flow cytometric analysis requires fewer cells and is less time-consuming than IP. Further, in contrast to IP, flow cytometry produces a quantifiable assessment of the percentage of cells containing activated Bak or Bax, which can be correlated with cell death.


Subject(s)
Flow Cytometry/methods , bcl-2 Homologous Antagonist-Killer Protein/chemistry , bcl-2 Homologous Antagonist-Killer Protein/metabolism , bcl-2-Associated X Protein/chemistry , bcl-2-Associated X Protein/metabolism , Animals , Antibodies/immunology , Antibodies/metabolism , Humans , Protein Conformation , bcl-2 Homologous Antagonist-Killer Protein/immunology , bcl-2-Associated X Protein/immunology
5.
Cold Spring Harb Protoc ; 2015(5): 485-9, 2015 May 01.
Article in English | MEDLINE | ID: mdl-25934940

ABSTRACT

Blue native PAGE (BN-PAGE) uses Coomassie dye rather than denaturing SDS to provide a negative charge to proteins for electrophoresis. As such, it is a useful assay for investigating native supramolecular membrane complexes without the need for cross-linking. As Bak and Bax oligomers form in the mitochondrial outer membrane, and they can be efficiently monitored by BN-PAGE. Furthermore, BN-PAGE performed in conjunction with gel-shift using conformation-specific antibodies can provide additional information regarding the activation state of Bak or Bax in specific membrane complexes.


Subject(s)
Antibodies/analysis , Electrophoretic Mobility Shift Assay/methods , Native Polyacrylamide Gel Electrophoresis/methods , Protein Multimerization , Staining and Labeling/methods , bcl-2 Homologous Antagonist-Killer Protein/metabolism , bcl-2-Associated X Protein/metabolism , Mitochondrial Membranes/metabolism , Protein Conformation , bcl-2 Homologous Antagonist-Killer Protein/chemistry , bcl-2 Homologous Antagonist-Killer Protein/immunology , bcl-2-Associated X Protein/chemistry , bcl-2-Associated X Protein/immunology
6.
PLoS Pathog ; 9(10): e1003658, 2013.
Article in English | MEDLINE | ID: mdl-24130482

ABSTRACT

The role of Type I interferon (IFN) during pathogenic HIV and SIV infections remains unclear, with conflicting observations suggesting protective versus immunopathological effects. We therefore examined the effect of IFNα/ß on T cell death and viremia in HIV infection. Ex vivo analysis of eight pro- and anti-apoptotic molecules in chronic HIV-1 infection revealed that pro-apoptotic Bak was increased in CD4+ T cells and correlated directly with sensitivity to CD95/Fas-mediated apoptosis and inversely with CD4+ T cell counts. Apoptosis sensitivity and Bak expression were primarily increased in effector memory T cells. Knockdown of Bak by RNA interference inhibited CD95/Fas-induced death of T cells from HIV-1-infected individuals. In HIV-1-infected patients, IFNα-stimulated gene expression correlated positively with ex vivo T cell Bak levels, CD95/Fas-mediated apoptosis and viremia and negatively with CD4+ T cell counts. In vitro IFNα/ß stimulation enhanced Bak expression, CD95/Fas expression and CD95/Fas-mediated apoptosis in healthy donor T cells and induced death of HIV-specific CD8+ T cells from HIV-1-infected patients. HIV-1 in vitro sensitized T cells to CD95/Fas-induced apoptosis and this was Toll-like receptor (TLR)7/9- and Type I IFN-dependent. This sensitization by HIV-1 was due to an indirect effect on T cells, as it occurred in peripheral blood mononuclear cell cultures but not purified CD4+ T cells. Finally, peak IFNα levels and viral loads correlated negatively during acute SIV infection suggesting a potential antiviral effect, but positively during chronic SIV infection indicating that either the virus drives IFNα production or IFNα may facilitate loss of viral control. The above findings indicate stage-specific opposing effects of Type I IFNs during HIV-1 infection and suggest a novel mechanism by which these cytokines contribute to T cell depletion, dysregulation of cellular immunity and disease progression.


Subject(s)
Apoptosis/immunology , CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , HIV Infections/immunology , HIV-1/immunology , Interferon-alpha/immunology , Interferon-beta/immunology , Up-Regulation/immunology , bcl-2 Homologous Antagonist-Killer Protein/immunology , Adolescent , Adult , Animals , CD4-Positive T-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/pathology , CD8-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/pathology , Child , Child, Preschool , Female , HIV Infections/metabolism , HIV Infections/pathology , HIV-1/metabolism , Humans , Immunity, Cellular , Infant , Interferon-alpha/metabolism , Interferon-beta/metabolism , Macaca mulatta , Male , Toll-Like Receptor 7/immunology , Toll-Like Receptor 7/metabolism , Toll-Like Receptor 9/immunology , Toll-Like Receptor 9/metabolism , Viral Load/immunology , Viremia/immunology , Viremia/metabolism , bcl-2 Homologous Antagonist-Killer Protein/biosynthesis , fas Receptor/immunology , fas Receptor/metabolism
7.
Proc Natl Acad Sci U S A ; 110(7): 2599-604, 2013 Feb 12.
Article in English | MEDLINE | ID: mdl-23349374

ABSTRACT

Dysregulation of the "intrinsic" apoptotic pathway is associated with the development of cancer and autoimmune disease. Bak and Bax are two proapoptotic members of the Bcl-2 protein family with overlapping, essential roles in the intrinsic apoptotic pathway. Their activity is critical for the control of cell survival during lymphocyte development and homeostasis, best demonstrated by defects in thymic T-cell differentiation and peripheral lymphoid homeostasis caused by their combined loss. Because most bak(-/-)bax(-/-) mice die perinatally, the roles of Bax and Bak in immunological tolerance and prevention of autoimmune disease remain unclear. We show that mice reconstituted with a Bak/Bax doubly deficient hematopoietic compartment develop a fatal systemic lupus erythematosus-like autoimmune disease characterized by hypergammaglobulinemia, autoantibodies, lymphadenopathy, glomerulonephritis, and vasculitis. Importantly, these mice also develop a multiorgan autoimmune disease with autoantibodies against most solid glandular structures and evidence of glandular atrophy and necrotizing vasculitis. Interestingly, similar albeit less severe pathology was observed in mice containing a hematopoietic compartment deficient for only Bak, a phenotype reminiscent of the disease seen in patients with point mutations in BAK. These studies demonstrate a critical role for Bak and an ancillary role for Bax in safeguarding immunological tolerance and prevention of autoimmune disease. This suggests that direct activators of the intrinsic apoptotic pathway, such as BH3 mimetics, may be useful for treatment of diverse autoimmune diseases.


Subject(s)
Apoptosis/immunology , Autoimmune Diseases/immunology , bcl-2 Homologous Antagonist-Killer Protein/immunology , bcl-2-Associated X Protein/immunology , Animals , Autoantibodies/immunology , Autoimmune Diseases/pathology , Blotting, Western , Chemokines/blood , Crosses, Genetic , Cytokines/blood , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Histological Techniques , Mice , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Fluorescence , bcl-2 Homologous Antagonist-Killer Protein/deficiency , bcl-2-Associated X Protein/deficiency
8.
J Immunol ; 187(11): 5684-92, 2011 Dec 01.
Article in English | MEDLINE | ID: mdl-22031758

ABSTRACT

Dendritic cells (DCs) harbor an active mitochondrion-dependent cell death pathway regulated by Bcl-2 family members and undergo rapid turnover in vivo. However, the functions for mitochondrion-dependent cell death of DCs in immune regulation remain to be elucidated. In this article, we show that DC-specific knockout of proapoptotic Bcl-2 family members, Bax and Bak, induced spontaneous T cell activation and autoimmunity in mice. In addition to a defect in spontaneous cell death, Bax(-/-)Bak(-/-) DCs were resistant to killing by CD4(+)Foxp3(+) T regulatory cells (Tregs) compared with wild-type DCs. Tregs inhibited the activation of T effector cells by wild-type, but not Bax(-/-)Bak(-/-), DCs. Bax(-/-)Bak(-/-) DCs showed increased propensity for inducing autoantibodies. Moreover, the autoimmune potential of Bax(-/-)Bak(-/-) DCs was resistant to suppression by Tregs. Our data suggested that Bax and Bak mediate intrinsic spontaneous cell death in DCs, as well as regulate DC killing triggered by Tregs. Bax- and Bak-dependent cell death mechanisms help to maintain DC homeostasis and contribute to the regulation of T cell activation and the suppression of autoimmunity.


Subject(s)
Apoptosis/immunology , Autoimmunity/immunology , Dendritic Cells/immunology , Self Tolerance/immunology , T-Lymphocytes, Regulatory/immunology , Adoptive Transfer , Animals , Cell Separation , Dendritic Cells/metabolism , Flow Cytometry , Immunohistochemistry , Lymphocyte Activation/immunology , Mice , Mice, Knockout , T-Lymphocytes, Regulatory/metabolism , bcl-2 Homologous Antagonist-Killer Protein/immunology , bcl-2 Homologous Antagonist-Killer Protein/metabolism , bcl-2-Associated X Protein/immunology , bcl-2-Associated X Protein/metabolism
9.
J Clin Immunol ; 30(1): 132-7, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19898928

ABSTRACT

INTRODUCTION: Ataxia telangiectasia (AT) is an autosomal recessive multisystem disorder characterized by variable immunodeficiency, progressive neurodegeneration, occulocutaneous telangiectasia, and an increased susceptibility to malignancies. This study was designed to study the role of proapoptotic BAK, BAX, and NBK/BIK genes in a group of patients with AT to elucidate the possible role of these genes in progression of malignancies in this disease. MATERIALS AND METHODS: Fifty Iranian patients with AT were investigated in this study. The entire coding regions of the BAK gene (exons 2-6), NBK/BIK gene (exons 2-5), and BAX gene (exons 1-7) were amplified using polymerase chain reaction (PCR). The PCR products were separated by 2% agarose gel electrophoresis, and all positive samples were verified by direct sequencing of PCR products using the same primers used for PCR amplification, BigDye chemistry, and Avent 3100 Genetic Analyzer following the manufacturer's instructions (Applied Biosystems). RESULTS: Eight of fifty Iranian AT patients (16%) exhibited a C > T transition in exon 2 (c342C > T) of the BAK gene, while none of the healthy controls had such alteration (P = 0.0001). Higher frequency of another nucleotide substitution in the noncoding region of exon 7 in BAX gene (6855G > A) was also identified in 68% of the patient group versus 24% in the controls (P < 0.0001). Sequence alteration in intronic region of the NBK/BIK gene IVS4-12delTC was observed in 52% of AT patients, which was significantly higher than 20% in the control group (P = 0.0023). Another variant IVS1146C > T in the intronic region of the BAX gene was found in 78% of patients, which was significantly higher than 10% in the controls (P < 0.0001). Frequency of alteration in intronic region of exon 3 of the BAX gene (IVS3 + 14A > G) was also significantly higher in the AT patients (P < 0.0001). DISCUSSION: Several alterations in the proapoptotic genes BAK, NBK/BIK, and BAX were found in our study, which could elucidate involvement of the mitochondrial pathway mediated apoptosis in accelerating and developing of cancers and in immunopathogenesis of AT. Such altered apoptosis in AT could play some roles in developing cancers in this group of patients.


Subject(s)
Apoptosis Regulatory Proteins/genetics , Ataxia Telangiectasia/genetics , Ataxia Telangiectasia/immunology , Membrane Proteins/genetics , bcl-2 Homologous Antagonist-Killer Protein/genetics , bcl-2-Associated X Protein/genetics , Adolescent , Apoptosis/genetics , Apoptosis Regulatory Proteins/immunology , Ataxia Telangiectasia/physiopathology , Child , DNA Mutational Analysis , Disease Progression , Exons/genetics , Female , Gene Frequency , Genetic Predisposition to Disease , Humans , Inteins/genetics , Iran , Male , Membrane Proteins/immunology , Mitochondrial Proteins , Mutation/genetics , Polymorphism, Genetic , bcl-2 Homologous Antagonist-Killer Protein/immunology , bcl-2-Associated X Protein/immunology
10.
Cell Death Differ ; 16(7): 991-1005, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19229247

ABSTRACT

Cross-presentation of cell-associated antigen is important in the priming of CD8(+) T-cell responses to proteins that are not expressed by antigen-presenting cells (APCs). In vivo, dendritic cells are the main cross-presenting APC, and much is known regarding their ability to capture and process cell-associated antigen. In contrast, little is known about the way death effector pathways influence the efficiency of cross-priming. Here, we compared two important mechanisms of programmed cell death: classical apoptosis, as it occurs in wild-type (WT) fibroblasts, and caspase-independent cell death, which occurs with increased features of autophagy in Bax/Bak(-/-) fibroblasts. We assessed virally infected WT and Bax/Bak(-/-) fibroblasts as a source of cell-associated antigen. We found that immunization with cells undergoing autophagy before cell death was superior in facilitating the cross-priming of antigen-specific CD8(+) T cells. Strikingly, silencing of Atg5 expression inhibited priming. We interpret this to be a novel form of 'immunogenic death' with the enhanced priming efficiency being a result of persistent MHC I cross-presentation and the induction of type I interferons. These results offer the first molecular evidence that catabolic pathways, including autophagy, influence the efficiency of cross-priming. We predict that targeting the autophagy cascade may provide a therapeutic strategy for achieving robust cross-priming of viral and tumor-specific CD8(+) T cells.


Subject(s)
Antigen Presentation/immunology , Apoptosis/immunology , Autophagy/immunology , CD8-Positive T-Lymphocytes/immunology , Cross-Priming/immunology , Dendritic Cells/immunology , Animals , Apoptosis/genetics , Autophagy/genetics , Autophagy-Related Protein 5 , CD8-Positive T-Lymphocytes/metabolism , Calreticulin/immunology , Calreticulin/metabolism , Dendritic Cells/metabolism , Fibroblasts/immunology , Fibroblasts/metabolism , Fibroblasts/virology , Gene Knockdown Techniques , Humans , Influenza A virus/immunology , Interferon Type I/immunology , Interferon Type I/metabolism , Lymphocyte Activation/immunology , Major Histocompatibility Complex/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/immunology , Microtubule-Associated Proteins/metabolism , Orthomyxoviridae Infections/immunology , Orthomyxoviridae Infections/virology , RNA, Small Interfering/metabolism , bcl-2 Homologous Antagonist-Killer Protein/genetics , bcl-2 Homologous Antagonist-Killer Protein/immunology , bcl-2 Homologous Antagonist-Killer Protein/metabolism , bcl-2-Associated X Protein/genetics , bcl-2-Associated X Protein/immunology , bcl-2-Associated X Protein/metabolism
11.
Immunobiology ; 212(8): 629-36, 2007.
Article in English | MEDLINE | ID: mdl-17869640

ABSTRACT

The process of thymopoiesis is tightly regulated by a series of selection events which ensure that only functional T-lymphocytes directed against foreign antigens are exported into the periphery. The adaptive immune response largely depends on the regulation of thymocyte development, and thymocytes which fail selection in the thymus are removed by apoptosis. However, the roles of specific apoptotic proteins in early T-lymphocyte development are poorly understood. Here, we report a novel function for Bim in thymocyte development. There is an accumulation of thymocytes in Bim(-/-) mice that lack expression of CD4, CD8, CD44, and CD25 but express CD3 and TCRbeta. Further, the CD4(-)CD8(-)CD25(-)CD44(-)CD3(+)TCRbeta(+) thymocytes are smaller and do not proliferate. These data suggest that these thymocytes are mature DN thymocytes that may have down-regulated the expression of CD4 and CD8. The DN thymocyte phenotype in Bim(-/-) mice is unaffected by the additional loss of Bak or Bax and is similar to the thymic phenotype in mice lacking both Bak and Bax. These data demonstrate that Bim functions to ensure the proper homeostasis of mature thymocytes during selection and thymic export.


Subject(s)
Antigens, CD/immunology , Apoptosis Regulatory Proteins/immunology , Cell Movement/immunology , Membrane Proteins/immunology , Organogenesis/immunology , Proto-Oncogene Proteins/immunology , T-Lymphocyte Subsets/immunology , T-Lymphocytes/immunology , Thymus Gland/cytology , Animals , Antigens, CD/genetics , Apoptosis/immunology , Bcl-2-Like Protein 11 , CD3 Complex/genetics , CD3 Complex/immunology , CD4 Antigens/genetics , CD4 Antigens/immunology , CD8 Antigens/genetics , CD8 Antigens/immunology , Cell Differentiation/immunology , Hyaluronan Receptors/genetics , Hyaluronan Receptors/immunology , Interleukin-2 Receptor alpha Subunit/genetics , Interleukin-2 Receptor alpha Subunit/immunology , Mice , Mice, Inbred C57BL , Mice, Transgenic , Organogenesis/genetics , Receptors, Antigen, T-Cell/immunology , Receptors, Antigen, T-Cell, alpha-beta/genetics , Receptors, Antigen, T-Cell, alpha-beta/immunology , Receptors, Lymphocyte Homing/immunology , Thymus Gland/immunology , bcl-2 Homologous Antagonist-Killer Protein/immunology , bcl-2-Associated X Protein/immunology
12.
J Exp Med ; 203(5): 1147-52, 2006 May 15.
Article in English | MEDLINE | ID: mdl-16651384

ABSTRACT

The introduction of antigen into animals causes antigen-specific T cells to divide and then die. Activated T cell death requires either of the death effector molecules, Bak or Bax. When T cells die, Bak and Bax change their conformations, a phenomenon that is thought to be required for Bak or Bax to drive cell death. Here we show that Bak changes conformation before activated T cells die, as detected by an antibody specific for a peptide near the NH2 terminus of Bak, but Bax does not change its shape markedly until after the cells are dead, as detected by an antibody specific for a peptide near the NH2 terminus of Bax. This latter finding is also true in activated T cells that lack Bak and are therefore dependent on Bax to die. This result suggests that Bax does not have to adopt its final, completely unfolded form until after the cells are dead.


Subject(s)
Lymphocyte Activation/immunology , Protein Folding , T-Lymphocytes/immunology , bcl-2 Homologous Antagonist-Killer Protein/immunology , bcl-2-Associated X Protein/immunology , Animals , Cell Death/immunology , Mice , Protein Conformation , bcl-2 Homologous Antagonist-Killer Protein/deficiency
13.
Proc Natl Acad Sci U S A ; 102(32): 11272-7, 2005 Aug 09.
Article in English | MEDLINE | ID: mdl-16055554

ABSTRACT

B cell homeostasis is maintained by a balance between the continual generation of new cells and their elimination. Here we show proapoptotic BCL-2 family members BAX and BAK are essential for regulating the number of B cells at both immature and mature developmental stages. BAX and BAK are critical mediators of B cell death induced by multiple stimuli. In addition, BAX- and BAK-deficient B cells display defective cell cycle progression to B cell receptor crosslinking and lipopolysaccharide, but not to CpG-DNA. Furthermore, inducible deletion of Bax and Bak in adult mice results in the development of severe autoimmune disease.


Subject(s)
Apoptosis/immunology , Autoimmune Diseases/immunology , B-Lymphocytes/immunology , bcl-2 Homologous Antagonist-Killer Protein/immunology , Animals , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/immunology , Bcl-2-Like Protein 11 , Flow Cytometry , Fluoresceins , Immunohistochemistry , Membrane Proteins/genetics , Membrane Proteins/immunology , Mice , Mice, Knockout , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins/immunology , Succinimides , bcl-2 Homologous Antagonist-Killer Protein/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...